With very few suppliers in the vaccination market, this creates an opportunity for India’s leading vaccine developer – Panacea Biotec Limited. Panacea
Categories
Health Care
NATCO Pharma Limited Q3FY23 Earnings
A pharmaceutical firm with a strong focus on research and development, NATCO Pharma Ltd creates, produces, and markets sophisticated pharmaceuticals for specialised
Narayana Hrudayalaya Q3FY23 Earnings Story
Affordable health care services are provided by Narayana Hrudayalaya Limited. There are several locations that make up its network of multispecialty and
Gufic Biosciences Limited Q3 FY23 Earnings Conference Call Insights
Key highlights from Gufic Biosciences Limited (GUFICBIO) Q3 FY23 Earnings Concall Q&A Highlights: [00:11:06] Gunit Singh from CCIPL enquired about the driver
Earnings | Alkem Laboratories Ltd.(NSE:ALKEM): Q3FY23 Results Out; Total Income rise 15% YoY
Alkem Laboratories Ltd.(NSE:ALKEM) is a pharmaceutical company based in India that specializes in the manufacturing and marketing of generic and branded drugs,
Gufic Biosciences Limited (GUFICBIO) Q3 FY23 Earnings Concall Transcript
Gufic Biosciences Limited (NSE:GUFICBIO) Q3 FY23 Earnings Concall dated Feb. 20, 2023. Corporate Participants: Ami Shah -- Company Secretary Avik Das -- Investor Relations D.B.Roonghta -- Chief Financial
Metropolis Healthcare Limited Q3FY23 Earnings
Metropolis Healthcare Limited is among the leading diagnostic companies in India. The company has a great geographical presence across nations including India,
Max Healthcare Inst. Limited Q3FY23 Earnings
Primary care clinics, multi-specialty hospitals / medical centres, and super-specialty hospitals are the main venues through which Max Healthcare Institute Limited offers
Wockhardt posted a net loss of INR 102 Crores in Q3FY23
Drugmaker Wockhardt posted a consolidated loss of ₹102 crore for the three months ended December 31, 2022. The company posted a profit
Earnings|Aarti Drugs Ltd (NSE:AARTIDRUGS): Q3FY23 Results Out; Total Income rise 4% YoY
Aarti Drugs Ltd (NSE:AARTIDRUGS) is a leading Indian pharmaceutical company that specializes in the manufacture and export of bulk drugs. The company
Earnings|Abbott India Ltd (NSE:ABBOTTINDIA) : Q3FY23 Results Out; Total Income rise 10% YoY
Abbott India Ltd (NSE:ABBOTTINDIA) is a subsidiary of the global healthcare company, Abbott Laboratories. It was established in 1944 and is headquartered
SMS Pharmaceuticals Ltd (SMSPHARMA) Q3 FY23 Earnings Concall Transcript
SMS Pharmaceuticals Ltd (NSE:SMSPHARMA) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Vamsi Krishna Potluri -- Executive Director Unidentified Speaker -- Analysts: Viraj
Orchid Pharma Ltd (ORCHPHARMA) Q3 FY23 Earnings Concall Transcript
Orchid Pharma Ltd (NSE: ORCHPHARMA) Q3 FY23 Earnings Concall dated Feb. 17, 2023 Corporate Participants: Manish Dhanuka -- Managing Director Mridul Dhanuka -- Executive Director Sunil
Poly Medicure Limited Q3FY23 Earnings Story
Poly Medicure Limited is an Indian company that deals with the manufacturing and exporting of medical devices. Some of its exported products
IPCA Laboratories Ltd (IPCALAB) Q3 FY23 Earnings Concall Transcript
IPCA Laboratories Ltd (NSE:IPCALAB) Q3 FY23 Earnings Concall dated Feb. 16, 2023. Corporate Participants: Ajit Kumar Jain -- Joint Managing Director Harish Kamath -- Corporate Counsel
Pfizer Limited Q3FY23 Earnings Story
Pfizer Ltd is primarily involved in marketing, exporting, manufacturing, and trading of pharmaceutical products. It produces goods through its in-house facility and
Caplin Point Laboratories Ltd. (NSE: CAPLIPOINT): Q3FY23 Results Out; Total Income rise 15% YoY
Caplin Point Laboratories Ltd. (NSE: CAPLIPOINT) is a pharmaceutical company based in India. It is engaged in the development, manufacture, and marketing
Shilpa Medicare Ltd (SHILPAMED) Q3 FY23 Earnings Concall Transcript
Shilpa Medicare Ltd (NSE: SHILPAMED) Q3 FY23 Earnings Concall dated Feb. 15, 2023 Corporate Participants: Vishnukanth Bhutada -- Managing Director Alpesh Dalal -- Chief Financial Officer
Supriya Lifescience Ltd (SUPRIYA) Q3 FY23 Earnings Concall Transcript
Supriya Lifescience Ltd (NSE:SUPRIYA) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Satish Wagh -- Chairman and Managing Director Saloni Wagh -- Director Krishna
Aster DM Healthcare Limited (ASTERDM) Q3 FY23 Earnings Concall Transcript
Aster DM Healthcare Limited (NSE:ASTERDM) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Azad Moopen -- Chairman and Managing Director Alisha Moopen -- Deputy
Sequent Scientific Limited (SEQUENT) Q3 FY23 Earnings Concall Transcript
Sequent Scientific Limited (NSE:SEQUENT) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Abhishek Singhal -- Investor Relations Rajaram Narayanan -- Managing Director P.V. Raghavendra